Justin J. McAnear - 23 May 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Financial Officer
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Justin J. McAnear
Issuer symbol
TXG
Transactions as of
23 May 2023
Net transactions value
-$91,682
Form type
4
Filing time
25 May 2023, 17:48:38 UTC
Previous filing
23 Mar 2023
Next filing
24 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $10,683 -194 -0.19% $55.07 101,933 23 May 2023 Direct F1, F2
transaction TXG Class A Common Stock Sale $25,604 -465 -0.46% $55.06 101,468 23 May 2023 Direct F1
transaction TXG Class A Common Stock Sale $24,283 -441 -0.43% $55.06 101,027 23 May 2023 Direct F1
transaction TXG Class A Common Stock Sale $31,111 -565 -0.56% $55.06 100,462 23 May 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
F2 Includes 617 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023.